Scientists investigated the impact of SIRT6-overexpression in Delta16HER2 mice, which were a bona fide model of HER2-positive breast cancer.
[Scientific Reports]
Home Newsletters Cancer Stem Cell News SIRT6 Promotes Metastasis and Relapse in HER2-Positive Breast Cancer
